We are live on ! Find out more
MS

Marshall & Sullivan Portfolio holdings

AUM $216M
1-Year Est. Return 12.97%
This Fund
S&P 500
This Quarter Est. Return
+0.32%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+98.09%
10 Year Est. Return
+292.06%
AUM
$71.2M
AUM Growth
+$11.2M
Cap. Flow
+$11.7M
Cap. Flow %
16.38%
Top 10 Hldgs %
40.19%
Holding
64
New
1
Increased
36
Reduced
4
Closed
17

Sector Composition

Rank Sector Weight
1 Healthcare 30.01%
2 Technology 18.3%
3 Consumer Staples 14.12%
4 Industrials 12.33%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$3.54M 4.97%
140,512
+12,120
+9% +$297K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.11T
$3.27M 4.6%
112,488
+17,608
+19% +$509K
FISV
3
Fiserv Inc
FISV
$29.7B
$3.21M 4.5%
99,188
+11,500
+13% +$363K
JNJ icon
4
Johnson & Johnson
JNJ
$640B
$2.77M 3.9%
26,017
+3,744
+17% +$388K
CHD icon
5
Church & Dwight Co
CHD
$23.7B
$2.75M 3.87%
78,494
+13,048
+20% +$444K
DHR icon
6
Danaher
DHR
$138B
$2.73M 3.84%
53,535
+7,890
+17% +$406K
HD icon
7
Home Depot
HD
$337B
$2.65M 3.72%
28,881
+4,799
+20% +$412K
PEP icon
8
PepsiCo
PEP
$196B
$2.59M 3.64%
27,799
+4,587
+20% +$419K
CL icon
9
Colgate-Palmolive
CL
$74.8B
$2.58M 3.62%
39,525
+6,720
+20% +$443K
QCOM icon
10
Qualcomm
QCOM
$164B
$2.51M 3.53%
33,573
+5,598
+20% +$428K
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
$2.49M 3.5%
42,066
+6,929
+20% +$454K
SYK icon
12
Stryker
SYK
$135B
$2.48M 3.48%
30,666
+5,198
+20% +$428K
ESRX
13
DELISTED
Express Scripts Holding Company
ESRX
$2.46M 3.46%
34,850
+6,144
+21% +$438K
RTX icon
14
RTX Corp
RTX
$290B
$2.44M 3.42%
36,677
+6,669
+22% +$457K
BDX icon
15
Becton Dickinson
BDX
$46.4B
$2.38M 3.34%
21,418
+3,752
+21% +$428K
AXE
16
DELISTED
Anixter International Inc
AXE
$2.36M 3.32%
27,866
+5,019
+22% +$456K
PX
17
DELISTED
Praxair Inc
PX
$2.36M 3.32%
18,306
+3,314
+22% +$435K
CTSH icon
18
Cognizant
CTSH
$26.5B
$2.32M 3.26%
51,766
+9,370
+22% +$441K
CCK icon
19
Crown Holdings
CCK
$13B
$2.28M 3.21%
51,315
+9,485
+23% +$456K
EMR icon
20
Emerson Electric
EMR
$81.6B
$2.18M 3.06%
34,809
+7,347
+27% +$477K
GILD icon
21
Gilead Sciences
GILD
$165B
$1.96M 2.75%
18,407
+2,936
+19% +$287K
CELG
22
DELISTED
Celgene Corp
CELG
$1.84M 2.59%
19,430
+3,991
+26% +$360K
MNST icon
23
Monster Beverage
MNST
$95.1B
$1.8M 2.53%
117,990
+29,898
+34% +$392K
TMO icon
24
Thermo Fisher Scientific
TMO
$214B
$1.69M 2.38%
13,895
+2,983
+27% +$363K
MA icon
25
Mastercard
MA
$498B
$1.67M 2.35%
22,605
+4,741
+27% +$361K

Similar funds

Marshall & Sullivan's Q3 2014 Portfolio in Review

As of Q3 2014, Marshall & Sullivan held 64 positions worth $71.2M, up 19% from $59.9M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Marshall & Sullivan deployed $11.7M of net new capital in Q3 2014, opening 1 new position and adding to 36 existing holdings. Its largest new stake was United Airlines: 23 shares worth $1K.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was McDonald's, an estimated $153K trimmed.

  • Marshall & Sullivan's largest Q3 2014 buy was United Airlines: 23 shares worth $1K.
  • Marshall & Sullivan added most to Alphabet (Google) Class C in Q3 2014, an estimated $509K increase.
  • Marshall & Sullivan's biggest Q3 2014 reduction was McDonald's, cutting an estimated $153K.
  • Marshall & Sullivan fully exited Berkshire Hathaway Class B in Q3 2014, selling an estimated $146K.
  • Marshall & Sullivan's ten largest holdings make up 40% of its $71.2M portfolio in Q3 2014.
  • Marshall & Sullivan opened 1 new position and closed 17 in Q3 2014.
  • Marshall & Sullivan's portfolio value rose 19% quarter-over-quarter to $71.2M.

Based on Marshall & Sullivan's 13F filing for Q3 2014, filed 14 Nov 2014.